Skip to content
27

tamiflu for adults no prescription

Skip it

Soft demand (-85.0% this quarter) — this niche doesn't clear our bar today.

Market size 4Growth 0Conversion 46Competition 12Returns 100Price range 72Avg price 78Brand share 0Review moat 24Quality gap 16

Returns

Incredible0.0%

return rate — above 6% kills the launch gate

Avg price

Great$16.10

avg listing price — sweet spot $15–$100

Price range

Good$7.39–$34.49

cheapest to priciest tracked listing — scored on the share inside $15–$100

Conversion

Okay3.7%

search→purchase rate — share of searches ending in a sale

Review moat

Bad5,471

avg incumbent reviews — the moat a new listing must climb

Quality gap

Bad4.8★

avg incumbent rating — lower means beatable quality

Competition

Bad86%

top-5 click share — a locked-up shelf

Market size

Bad$17K

$17K/yr · 29K searches

Growth

Bad-85.0%

90-day search growth — must beat 0% to launch

Brand share

Bad100%

top-5 brand share — brand-locked demand

Competition

The top 5 products capture 86% of clicks — a locked-up shelf that new listings rarely crack.

Brands

3 falling

Sellers

617

Top-5 brand share

100%

Open market

0%

  • Boiron64%
  • Theraflu33%
  • Tylenol4%
  • Open — no brand owns it (0%)

Product shelf

Each bubble is one product — market share against review moat; bubble size tracks estimated sales, color grades how beatable the incumbent looks.

0%10%$2K20%$3K30%$5K40%$7K1001K10K100K Reviews — right = deep review moat Market share (90d) ≈ est. sales
Beatable (≤4.3★) Contested Strong incumbent (>4.7★)

All 8 tracked products in this niche — three views at once, no toggling.

Demand & seasonality

Weekly Amazon search volume, last 75 weeks — -85.0% search growth over the last 90 days.
8K6KSpike '25Black Friday '25Spike '26FebMarAprMayJunJulAugSepOctNovDecJanFebMarAprMayJun

Peak months: Jan, Feb, Dec · busiest ÷ quietest = 23.2×